Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana L Brassard

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Leukocyte Biology|April 3, 2002
Interferon-alpha as an immunotherapeutic proteinDiana L Brassard, Michael J Grace, Ronald W Bordens
Experimental Cell Research|February 2, 2002
Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-RasDiana L Brassard, Jessie M English, Michael Malkowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cellsKeyur Vyas, Diana L Brassard, Marc M DeLorenzo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 24, 2004
Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cellsDiana L Brassard, Marc M Delorenzo, Stuart Cox, et al.
The Journal of Biological Chemistry|July 26, 2002
Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cellsQun Wu, Paul Kirschmeier, Tish Hockenberry, et al.
Leukemia & Lymphoma|November 6, 2012
SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemiasBernard Bourrié, Diana L Brassard, Sylvie Cosnier-Pucheu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Leukocyte Biology|April 3, 2002
Interferon-alpha as an immunotherapeutic proteinDiana L Brassard, Michael J Grace, Ronald W Bordens
Experimental Cell Research|February 2, 2002
Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-RasDiana L Brassard, Jessie M English, Michael Malkowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cellsKeyur Vyas, Diana L Brassard, Marc M DeLorenzo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 24, 2004
Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cellsDiana L Brassard, Marc M Delorenzo, Stuart Cox, et al.
The Journal of Biological Chemistry|July 26, 2002
Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cellsQun Wu, Paul Kirschmeier, Tish Hockenberry, et al.
Leukemia & Lymphoma|November 6, 2012
SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemiasBernard Bourrié, Diana L Brassard, Sylvie Cosnier-Pucheu, et al.
Pageof 1